[This article was reported on "Radar M," a paid media outlet specializing in the capital market of Mail Business, on July 02 (17:38)]
Remedy, a low-dose and ultra-small X-ray solution company, announced on the 2nd that it recorded a competition ratio of 1,707 to 1 in public offering shares for two days from the 1st to the 2nd of this month.
A total of 51.2 million shares were received for 300,000 general investors. The number of subscriptions is 316,557. As a result, the subscription deposit was tallied at 5.3 trillion won. The organizer is KB Securities.
Demand previously conducted from the 17th to the 23rd of last monthA total of 2,246 organizations participated in the forecast, recording a competition ratio of 1,146 to 1. The public offering price was confirmed at 20,700 won, the upper end of the desired range (17,800 won to 20,700 won).
The company will be listed on the KOSDAQ market on the 13th of this month after payment on the 6th. The funds secured by listing will be used to expand production capacity (CAPA), advance R&D, and strengthen overseas certification and sales networks.
